See All Slides - tctmd.com

Slides

Presentation ESC 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Presenter: Alvaro Avezum

September 03, 2013

Presentation ESC 2013

Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE trial)

Presenter: Ole Fr?bert

September 01, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

Presentation

Designation as ‘Unfit for Open Repair’ Is Associated with Poor Outcomes After EVAR

Presenter: Randall R. De Martino

August 30, 2013

Presentation

Granulocyte Colony-Stimulating Factor (G-CSF) in Patients with Acute Ischemic Stroke

Presenter: E. Bernd Ringelstein

August 29, 2013

Presentation

Ambulatory Percutaneous EVAR

Presenter: Hasan H. Dosluoglu

August 29, 2013

Presentation

Stroke or TIA in Patients with Transvenous Pacemaker or Defibrillator and Echo-Detected PFO

Presenter: C. V. DeSimone

August 28, 2013

Presentation

Does Ascorbic Acid Protect Against Contrast-Induced Acute Kidney Injury (AKI) in Patients Undergoing Coronary Angiography?

Presenter: Umar Sadat

August 28, 2013

Presentation

Atrial Fibrillation in MI Patients: Impact on Health Care Utilization

Presenter: A.M. Chamberlain

August 27, 2013

Presentation

Higher Risk of Recurrent Ischemic Events in Patients with Intracranial In-Stent Restenosis

Presenter: M. Jin

August 27, 2013

Advertisement

Slides

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE trial)

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Designation as ‘Unfit for Open Repair’ Is Associated with Poor Outcomes After EVAR

Granulocyte Colony-Stimulating Factor (G-CSF) in Patients with Acute Ischemic Stroke

Ambulatory Percutaneous EVAR

Stroke or TIA in Patients with Transvenous Pacemaker or Defibrillator and Echo-Detected PFO

Does Ascorbic Acid Protect Against Contrast-Induced Acute Kidney Injury (AKI) in Patients Undergoing Coronary Angiography?

Atrial Fibrillation in MI Patients: Impact on Health Care Utilization

Higher Risk of Recurrent Ischemic Events in Patients with Intracranial In-Stent Restenosis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content